Schena FP - Search Results

1

MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma.

Tatsumi T, Kierstead LS, Ranieri E, Gesualdo L, Schena FP, Finke JH, Bukowski RM, Brusic V, Sidney J, Sette A, Logan TF, Kasamon YL, Slingluff CL Jr, Kirkwood JM, Storkus WJ. Tatsumi T, et al. Among authors: schena fp. Clin Cancer Res. 2003 Mar;9(3):947-54. Clin Cancer Res. 2003. PMID: 12631591

2

Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma.

Tatsumi T, Kierstead LS, Ranieri E, Gesualdo L, Schena FP, Finke JH, Bukowski RM, Mueller-Berghaus J, Kirkwood JM, Kwok WW, Storkus WJ. Tatsumi T, et al. Among authors: schena fp. J Exp Med. 2002 Sep 2;196(5):619-28. doi: 10.1084/jem.20012142. J Exp Med. 2002. PMID: 12208877 Free PMC article.

3

Renal biopsy--beyond histology and immunofluorescence.

Schena FP, Gesualdo L. Schena FP, et al. Nephrol Dial Transplant. 1994;9(11):1541-4. Nephrol Dial Transplant. 1994. PMID: 7870339 Review. No abstract available.

4

Pathogenetic mechanisms of diabetic nephropathy.

Schena FP, Gesualdo L. Schena FP, et al. J Am Soc Nephrol. 2005 Mar;16 Suppl 1:S30-3. doi: 10.1681/asn.2004110970. J Am Soc Nephrol. 2005. PMID: 15938030 Review.

5

Dexamethasone modulates interleukin-12 production by inducing monocyte chemoattractant protein-1 in human dendritic cells.

Roca L, Di Paolo S, Petruzzelli V, Grandaliano G, Ranieri E, Schena FP, Gesualdo L. Roca L, et al. Among authors: schena fp. Immunol Cell Biol. 2007 Nov-Dec;85(8):610-6. doi: 10.1038/sj.icb.7100108. Epub 2007 Aug 14. Immunol Cell Biol. 2007. PMID: 17700511

6

Trapidil inhibits human mesangial cell proliferation: effect on PDGF beta-receptor binding and expression.

Gesualdo L, Di Paolo S, Ranieri E, Schena FP. Gesualdo L, et al. Among authors: schena fp. Kidney Int. 1994 Oct;46(4):1002-9. doi: 10.1038/ki.1994.360. Kidney Int. 1994. PMID: 7861694 Free article.

7

Markers of progression in IgA nephropathy.

Schena FP, Gesualdo L. Schena FP, et al. J Nephrol. 2001 Nov-Dec;14(6):554-74. J Nephrol. 2001. PMID: 11783611 No abstract available.

8

Growth factors and their receptors in the progression of renal damage.

Gesualdo L, Di Paolo S, Ranieri E, Schena FP. Gesualdo L, et al. Among authors: schena fp. Contrib Nephrol. 1995;111:38-44. doi: 10.1159/000423875. Contrib Nephrol. 1995. PMID: 7758345 Review. No abstract available.

9

Protease-activated receptor-2 expression in IgA nephropathy: a potential role in the pathogenesis of interstitial fibrosis.

Grandaliano G, Pontrelli P, Cerullo G, Monno R, Ranieri E, Ursi M, Loverre A, Gesualdo L, Schena FP. Grandaliano G, et al. Among authors: schena fp. J Am Soc Nephrol. 2003 Aug;14(8):2072-83. doi: 10.1097/01.asn.0000080315.37254.a1. J Am Soc Nephrol. 2003. PMID: 12874461

10

Monitoring biological action of rapamycin in renal transplantation.

Leogrande D, Teutonico A, Ranieri E, Saldarelli M, Gesualdo L, Schena FP, Di Paolo S. Leogrande D, et al. Among authors: schena fp. Am J Kidney Dis. 2007 Aug;50(2):314-25. doi: 10.1053/j.ajkd.2007.05.002. Am J Kidney Dis. 2007. PMID: 17660033 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

464 results

Search Page

Filters